Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

(603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Notice on Convening the 6th Extraordinary General Meeting in 2026

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603139 · · 6 pages · Chinese

Summary by 6ix AI

The meeting will take place in late October and will include both on-site and online voting options for shareholders. Key agenda items for the meeting include proposals related to increasing credit limits and providing guarantees for subsidiaries. Shareholders must register to attend the meeting and can delegate their voting rights to representatives if needed.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603139shaanxi-kanghui-pharmaceutical-co-ltdnotice-on-convening-the-6th-extraordinary-general-meeting-in-2026

Release

Notice on Convening the 6th Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases